Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-18 · accession 0000950170-25-023192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | KPTI | Poulton Stuart | EVP, Chief Development Off | S - Sale | $0.63 | -5,914 | 320.7K | -2% | -$3,726 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 5,914 | $0.63 | 320,714 | D | — | — |